Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2

Journal of Immunology

Volumn 187, Issue 4, 2011, Pages 1692-1701

  Chua, Brendon Y ^a   Pejoski, David ^a   Turner, Stephen J ^a   Zeng, Weiguang ^a   Jackson, David C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIONIC LIPOPEPTIDE; ANTIGEN; CATIONIC LIPOPEPTIDE; DIPALMITOYL S GLYCERYL CYSTEINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; LIPOPEPTIDE; OVALBUMIN; SODIUM CHLORIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD8+ T LYMPHOCYTE; CELL PH; CELL TRANSPORT; CELLULAR IMMUNITY; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG TARGETING; FEMALE; IMMUNOGENICITY; IN VIVO STUDY; INFLUENZA; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; SURFACE CHARGE; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; IMMUNOGLOBULIN G; INFLUENZA VACCINES; LIPOPEPTIDES; MICE; NEURAMINIDASE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; SOLUBILITY; STATIC ELECTRICITY; TOLL-LIKE RECEPTOR 2; VACCINATION; VIRAL PROTEINS;

EID: 80051942781     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100486     Document Type: Article

References (37)

1. Mesa, C., and L. E. Fernández. 2004. Challenges facing adjuvants for cancer immunotherapy. Immunol. Cell Biol. 82: 644-650. (Pubitemid 39563965)
2. Pashine, A., N. M. Valiante, and J. B. Ulmer. 2005. Targeting the innate immune response with improved vaccine adjuvants. Nat. Med. 11(4, Suppl)S63-S68. (Pubitemid 40562305)
3. McMichael, A., and T. Hanke. 2002. The quest for an AIDS vaccine: Is the CD8 + T-cell approach feasible? Nat. Rev. Immunol. 2: 283-291. (Pubitemid 37323228)
4. Seder, R. A., and A. V. Hill. 2000. Vaccines against intracellular infections requiring cellular immunity. Nature 406: 793-798.
5. Lahiri, A., P. Das, and D. Chakravortty. 2008. Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond. Vaccine 26: 6777-6783.
6. Van Duin, D., R. Medzhitov, and A. C. Shaw. 2006. Triggering TLR signaling in vaccination. Trends Immunol. 27: 49-55. (Pubitemid 43083564)
7. Ingale, S., M. A. Wolfert, T. Buskas, and G. J. Boons. 2009. Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors. ChemBioChem 10: 455-463.
8. Zeng, W., S. Ghosh, Y. F. Lau, L. E. Brown, and D. C. Jackson. 2002. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. J. Immunol. 169: 4905-4912. (Pubitemid 35217155)
9. Heit, A., T. Maurer, H. Hochrein, S. Bauer, K. M. Huster, D. H. Busch, and H. Wagner. 2003. Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells. J. Immunol. 170: 2802-2805. (Pubitemid 36302148)
10. Khan, S., M. S. Bijker, J. J. Weterings, H. J. Tanke, G. J. Adema, T. Van Hall, J. W. Drijfhout, C. J. Melief, H. S. Overkleeft, G. A. Van der Marel, et al. 2007. Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells. J. Biol. Chem. 282: 21145-21159. (Pubitemid 47099911)
11. Maurer, T., A. Heit, H. Hochrein, F. Ampenberger, M. O'Keeffe, S. Bauer, G. B. Lipford, R. M. Vabulas, and H. Wagner. 2002. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells. Eur. J. Immunol. 32: 2356-2364. (Pubitemid 34965899)
12. Tighe, H., K. Takabayashi, D. Schwartz, R. Marsden, L. Beck, J. Corbeil, D. D. Richman, J. J. Eiden, Jr., H. L. Spiegelberg, and E. Raz. 2000. Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity. Eur. J. Immunol. 30: 1939-1947. (Pubitemid 30456190)
13. Wille-Reece, U., B. J. Flynn, K. Loré, R. A. Koup, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, and R. A. Seder. 2005. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc. Natl. Acad. Sci. USA 102: 15190-15194. (Pubitemid 41513357)
14. Wille-Reece, U., C. Y. Wu, B. J. Flynn, R. M. Kedl, and R. A. Seder. 2005. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses. J. Immunol. 174: 7676-7683. (Pubitemid 40806272)
15. Prajeeth, C. K., A. C. Jirmo, J. K. Krishnaswamy, T. Ebensen, C. A. Guzman, S. Weiss, H. Constabel, R. E. Schmidt, and G. M. Behrens. 2010. The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens. Eur. J. Immunol. 40: 1272-1283.
16. Shirota, H., K. Sano, N. Hirasawa, T. Terui, K. Ohuchi, T. Hattori, K. Shirato, and G. Tamura. 2001. Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells. J. Immunol. 167: 66-74. (Pubitemid 32567762)
17. Blander, J. M., and R. Medzhitov. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
18. Mühlradt, P. F., M. Kiess, H. Meyer, R. Süssmuth, and G. Jung. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185: 1951-1958. (Pubitemid 27247081)
19. Chua, B. Y., W. Zeng, Y. F. Lau, and D. C. Jackson. 2007. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups. Vaccine 25: 92-101. (Pubitemid 44855240)
20. Deliyannis, G., D. C. Jackson, N. J. Ede, W. Zeng, I. Hourdakis, E. Sakabetis, and L. E. Brown. 2002. Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus. J. Virol. 76: 4212-4221. (Pubitemid 34309556)
21. Jackson, D. C., Y. F. Lau, T. Le, A. Suhrbier, G. Deliyannis, C. Cheers, C. Smith, W. Zeng, and L. E. Brown. 2004. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 101: 15440-15445. (Pubitemid 39441560)
22. Lau, Y. F., G. Deliyannis, W. Zeng, A. Mansell, D. C. Jackson, and L. E. Brown. 2006. Lipid-containing mimetics of natural triggers of innate immunity as CTLinducing influenza vaccines. Int. Immunol. 18: 1801-1813. (Pubitemid 44884042)
23. Chua, B. Y., E. M. Eriksson, D. P. Poole, W. Zeng, and D. C. Jackson. 2008. Dendritic cell acquisition of epitope cargo mediated by simple cationic peptide structures. Peptides 29: 881-890.
24. Zeng, W., D. C. Jackson, and K. Rose. 1996. Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry. J. Pept. Sci. 2: 66-72. (Pubitemid 126495398)
25. Jenkins, M. R., R. Webby, P. C. Doherty, and S. J. Turner. 2006. Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting. J. Immunol. 177: 2917-2925. (Pubitemid 44277807)
26. Tannock, G. A., J. A. Paul, and R. D. Barry. 1984. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect. Immun. 43: 457-462. (Pubitemid 14181583)
27. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185: 317-328. (Pubitemid 27078288)
28. Shirota, H., K. Sano, T. Kikuchi, G. Tamura, and K. Shirato. 2000. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J. Immunol. 164: 5575-5582. (Pubitemid 30389796)
29. Glaum, M. C., S. Narula, D. Song, Y. Zheng, A. L. Anderson, C. H. Pletcher, and A. I. Levinson. 2009. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production. J. Allergy Clin. Immunol. 123:224-230.e4.
30. Richard, K., S. K. Pierce, and W. Song. 2008. The agonists of TLR4 and 9 are sufficient to activate memory B cells to differentiate into plasma cells in vitro but not in vivo. J. Immunol. 181: 1746-1752.
31. Eckl-Dorna, J., and F. D. Batista. 2009. BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation. Blood 113: 3969-3977.
32. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: Up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504. (Pubitemid 36857820)
33. Good, K. L., D. T. Avery, and S. G. Tangye. 2009. Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J. Immunol. 182: 890-901.
34. Kushnir, N., L. Liu, and G. G. MacPherson. 1998. Dendritic cells and resting B cells form clusters in vitro and in vivo: T cell independence, partial LFA-1 dependence, and regulation by cross-linking surface molecules. J. Immunol. 160: 1774-1781. (Pubitemid 28106463)
35. Wykes, M., and G. MacPherson. 2000. Dendritic cell-B-cell interaction: Dendritic cells provide B cells with CD40-independent proliferation signals and CD40-dependent survival signals. Immunology 100: 1-3. (Pubitemid 30242875)
36. Wykes, M., A. Pombo, C. Jenkins, and G. G. MacPherson. 1998. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161: 1313-1319. (Pubitemid 28380559)
37. Berney, C., S. Herren, C. A. Power, S. Gordon, L. Martinez-Pomares, and M. H. Kosco-Vilbois. 1999. A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein. J. Exp. Med. 190: 851-860. (Pubitemid 29451630)